Abstract

F
We'll be including several reflections on the history of pharmacy in Canada (starting with our covers), as our publisher, the Canadian Pharmacists Association, celebrates its centennial year. We still have a lot to learn from our predecessors in this profession and need to be reminded not to repeat mistakes made in the past, particularly when dealing with expanded scopes of practice (see Notes, pages 13 and 18).
We will be expanding our content relating to the pharmacist's role in public health, whether it be participation in structured, government-sanctioned programs like emergency preparedness, vaccination, and harm reduction (see this month's practice profile on page 25) or the unrecognized public health efforts of individual pharmacists in areas such as the prevention of HIV/AIDS and West Nile disease. We will continue to publish themed supplements (see Collaborative Care enclosed with this issue) and pharmacist-specific guidelines on a variety of topics and will introduce new columns and features to our readers as the year progresses — all with the aim of making it easier for our readers to translate knowledge into practice.
What can readers expect from CPJ in 2007?
Most importantly, we will be working to broaden the reach of CPJ, the only peer-reviewed journal published for community pharmacists in Canada and one of very few publications in the world dedicated to the advancement of pharmacy practice. As our Editorial Board Chair, Ross Tsuyuki, explains in this issue's guest editorial, CPJ is providing a forum for disseminating the work of pharmacy practice researchers — a role that is crucial in a country where almost 25% of hospital admissions can be attributed to largely preventable drug-related incidents 3 (see Notes on page 14). If Canadian pharmacists are to be appropriately recognized and compensated for their ability to identify, solve, and prevent drug-related problems, we must be able to provide evidence of the value of these interventions and our ability to perform them consistently. Governments and third-party payers are justified in demanding Canadian “proof” of pharmacists' claims and our capacity for non-dispensing activities — studies from the UK and Australia just won't cut it. Despite many laudable efforts in various parts of the country, it would appear from recent research that we still have a long way to go (see pages 23 and 32) to provide these interventions across the spectrum of community practice sites.
As we move forward in responding to the challenges and opportunities that 2007 will offer, we need to hear what
I wish you all a happy, healthy, and prosperous New Year!
